Cormorant Asset Management sold 50,000 shares of PRAX in Q4, an estimated $9.31 million transaction based on quarterly average pricing. The trade signals a reduction in Cormorant's exposure and constitutes modest selling pressure unlikely to materially move PRAX's market price given the reported size.
Cormorant Asset Management sold 50,000 shares of PRAX in Q4, an estimated $9.31 million transaction based on quarterly average pricing. The trade signals a reduction in Cormorant's exposure and constitutes modest selling pressure unlikely to materially move PRAX's market price given the reported size.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
